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Interaction of Plectin with Keratins 5 and 14:
Dependence on Several Plectin Domains and Keratin
Quaternary Structure
Jamal-Eddine Bouameur1,2,3,5, Bertrand Favre1,2,5, Lionel Fontao4,5, Prakash Lingasamy1,2, Nadja Begre´1,2 and
Luca Borradori1,2
Plectin, a cytolinker of the plakin family, anchors the intermediate filament (IF) network formed by keratins 5
and 14 (K5/K14) to hemidesmosomes, junctional adhesion complexes in basal keratinocytes. Genetic alterations
of these proteins cause epidermolysis bullosa simplex (EBS) characterized by disturbed cytoarchitecture and
cell fragility. The mechanisms through which mutations located after the documented plectin IF-binding
site, composed of the plakin-repeat domain (PRD) B5 and the linker, as well as mutations in K5 or K14, lead to
EBS remain unclear. We investigated the interaction of plectin C terminus, encompassing four domains, the
PRD B5, the linker, the PRD C, and the C extremity, with K5/K14 using different approaches, including a rapid and
sensitive fluorescent protein–binding assay, based on enhanced green fluorescent protein-tagged proteins
(FluoBACE). Our results demonstrate that all four plectin C-terminal domains contribute to its association
with K5/K14 and act synergistically to ensure efficient IF binding. The plectin C terminus predominantly interacted
with the K5/K14 coil 1 domain and bound more extensively to K5/K14 filaments compared with monomeric
keratins or IF assembly intermediates. These findings indicate a multimodular association of plectin with K5/K14
filaments and give insights into the molecular basis of EBS associated with pathogenic mutations in plectin, K5,
or K14 genes.
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INTRODUCTION
Plectin is a large ubiquitous cytolinker protein of the plakin
family (Sonnenberg and Liem, 2007; Winter and Wiche, 2013;
Bouameur et al., 2014). Several plectin isoforms with distinct
N termini exist. They exhibit specific tissue expression and
subcellular distribution. In basal keratinocytes, plectin and the
epithelial isoform of BPAG1 (BPAG1e), another plakin family
member, anchor the intermediate filament (IF) network formed
by keratins 5 and 14 (K5/K14) to the basal cell membrane
through their association with transmembrane a6b4 integrin
and BP180 (also called bullous pemphigoid antigen 2 or
collagen type XVII) (Guo et al., 1995; Andra¨ et al., 1997;
Borradori and Sonnenberg, 1999; Walko et al., 2011). In
striated muscle, plectin has a key role in tethering the desmin
IF network to the Z-discs, between the peripheral myofibrils
and the sarcolemma, as well as to the intercalated discs
(Andra¨ et al., 1997; Konieczny et al., 2008). Structurally, all
plectin variants possess the same C-terminal tail composed
of a succession of six plakin-repeat domains (PRDs) linked
by connecting segments and ending with a C extremity (E)
containing glycine-serine-arginine repeats (see Figure 1).
A 50-amino-acid stretch immediately following the fifth PRD
B (B5), in the so-called ‘‘linker’’ (L), is important for the
binding of plectin to various IF types (Nikolic et al., 1996;
Favre et al., 2011; Karashima et al., 2012) (see Figure 1).
Recent studies have shown that plectin specifically binds to
the central rod domain of type III IF proteins vimentin and
desmin (Favre et al., 2011).
IFs are involved in a variety of cell functions, including
maintenance of cell resilience and cytoarchitecture
(Herrmann et al., 2009; Ramms et al., 2013; Seltmann et al.,
2013). This family comprises six types of protein whose
expression is cell-type specific and depends on tissue
differentiation (Herrmann and Aebi, 2004; Szeverenyi et al.,
2008). Structurally, they consist of a central a-helical rod
domain flanked by N- and C-terminal ‘‘head’’ and ‘‘tail’’
domains, respectively. Their dimerization is mediated by
their rod, whereas their subsequent stepwise assembly in
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unit-length filaments and in long insoluble filaments requires
their head. Their final radial compaction is enabled by their
tail. Keratin IFs are obligatory heteropolymers assembled from
type I and II keratin heterodimers that are mostly expressed in
epithelial cells, whereas type III vimentin and desmin IFs are
homopolymers expressed in mesenchymal and muscular
tissues, respectively (Steinert and Roop, 1988). Genetic
defects in humans, as well as gene-targeted elimination of
K5, K14, plectin, or BPAG1e in mice, cause cytoskeletal dis-
organization and loss of cytokeratin anchorage to hemide-
smosomes, resulting in an epidermolysis bullosa simplex
phenotype (Guo et al., 1995; Andra¨ et al., 1997; Coulombe
and Omary, 2002; Porter and Lane, 2003; Intong and Murrell,
2012; Liu et al., 2012; Winter and Wiche, 2013). Plectin or
desmin gene defects also result in muscular dystrophy (Andra¨
et al., 1997; Winter and Wiche, 2013), accompanied by
disorganization of the desmin IF network and malposition
of mitochondria (Capetanaki et al., 2007). These findings
unequivocally demonstrate the importance of the interplay
between IFs and plakins for the maintenance of the
cytoarchitecture in the skin and in skeletal muscle.
A surprising cause of epidermolysis bullosa simplex-mus-
cular dystrophy is the truncating mutations in the plectin’s last
PRD (PRD C) or even in the C extremity (Schro¨der et al., 2002;
Winter and Wiche, 2013), as these domains are not crucial for
plectin binding to IFs in contrast to the preceding linker region
(Nikolic et al., 1996) (see Figure 1). There is some evidence
that other sequences within the plectin C terminus are
involved in its binding to IFs, but their exact contribution is
still unclear (Nikolic et al., 1996; Favre et al., 2011; Karashima
et al., 2012; Bouameur et al., 2013). Last but not least, distinct
binding sites for plakins have been identified on various IF
proteins (Kouklis et al., 1994; Meng et al., 1997; Fontao et al.,
2003), although the involvement of a common conserved
region within IF proteins in their binding to distinct plakins
seems more plausible on the basis of recent findings (Lapouge
et al., 2006; Favre et al., 2011).
Here, we have characterized the interaction of K5/K14 with
plectin by using several independent methods. Grouped
together, our findings provide insights into the association of
plectin with IFs, as well as a better understanding of the
molecular basis of inherited diseases associated with plectin
and cytokeratin defects.
RESULTS AND DISCUSSION
The IF-binding domain of plectin interacts preferentially with the
type I keratins K14, K10, and K18
The plectin C terminus was found to colocalize with cytoker-
atins in transfected cells (Nikolic et al., 1996) and to interact
with K14 but not with K5 in yeast two-hybrid assays (Geerts
et al., 1999). However, the preferential binding to K14 was not
confirmed in a separate study using biochemical binding
assays with a recombinant plectin encompassing the PRD
B5 and the linker region (PL-B5-L). Furthermore, the interac-
tion of this recombinant protein with K5/K14 polymers was
modest compared with monomeric keratins (Steinbock et al.,
2000). To better characterize the interaction of plectin with
type I and type II keratins in vitro, we expressed in bacteria a
recombinant PL-B5-L protein tagged at its N terminus with
H6-enhanced green fluorescent protein (EGFP) (H6-EGFP-PL-
B5-L) (see Figure 1). Recombinant H6-EGFP-PL-B5-L and
EGFP-H6, the latter used as control and standard to determine
the concentration of EGFP-tagged proteins in solution, were
purified from soluble bacterial extracts in nondenaturing
conditions (Supplementary Figure S1a–c online) and their
interaction with various recombinant IF proteins (see
Supplementary Figure S2 online) was analyzed. In our binding
assays, the IF proteins were (1) directly spotted onto nitrocel-
lulose membrane, (2) subjected to SDS-PAGE and then
transferred onto nitrocellulose membrane, or (3) immobilized
on the plastic surface of ELISA-microtiter plate wells (see
Supplementary Materials and Methods online), whereas H6-
EGFP-PL-B5-L was used as the liquid-phase ligand (fluorescent
overlay or sorbent assays, respectively). H6-EGFP-PL-B5-L
preferentially interacted with monomeric K14 rather than with
monomeric K5, in agreement with yeast two-hybrid results
(Geerts et al., 1999), and even better with dimeric K5/K14
with a Kd of 135 nM±36 (mean±SD from five independent
COILED COIL
1 71 285 309
2 1 2 3 4 6 7 8 9 B1 B2 B3 B4 B5 C1
 2647    2729 4574
5
CHs SRs
SH3 L E
PRDs
B5 CL EPL-B5-E
B5 CLPL-B5-C
B5
L
PL-B5-L
CPL-C-E
CPL-C
E
K4460X
13457
ins16
COILED COIL2 1 2 3 4 6 7 8 9 B1 B2 B31 5 PL-ΔB4-E
Human plectin 1c (PL)
1368 1369
Figure 1. Schematic of the structure of human plectin 1c and of truncation mutants used in this study. The actin-binding domain consists of two calponin
homology domains (CHs, pale blue). The plakin domain is composed of the spectrin repeats (SRs, green) 3 to 9, with an atypical SH3 domain (white) embedded in
the fifth SR. The C-tail comprises plakin-repeat domains (PRDs, yellow: type B, orange: type C) and connecting segments including the linker (L, red) and the C
extremity (E, violet). Residue numbers and the location of two truncating mutations found in patients suffering from epidermolysis bullosa simplex-muscular
dystrophy are also indicated. The N terminus of the two biggest constructs was hemagglutinin-tagged and that of the smaller constructs was fused to either
enhanced green fluorescent protein (EGFP) or H6-EGFP.
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experiments) (Figure 2a–c, Supplementary Figure S3 online).
H6-EGFP-PL-B5-L bound also more to K10 and K18 than to K1
and K8, respectively (Figure 2a and Supplementary Figure S3
online), indicating a preferential interaction with monomeric
type I keratins rather than with type II keratins. A possible
explanation for the discrepancies between our findings and a
previous study (Steinbock et al., 2000) is that these authors
used immobilized H6-PL-B5-L, purified from inclusion bodies
(Nikolic et al., 1996), and randomly europium-labeled
keratins as fluid-phase ligands.
As the production of plectin fragments as soluble and active
proteins in bacteria is often ineffective (Nikolic et al., 1996;
Spurny et al., 2007) (our own unpublished data), we trans-
fected mammalian cells, which ensure better protein folding
compared with bacteria (Hartl et al., 2011), to produce several
EGFP-tagged recombinant forms of plectin (Supplementary
Figure S1d–f online). The soluble extracts from transfected
HEK 293T cells were used as the liquid phase in overlay
assays (FluoBACE) by analogy with the single-molecule pull-
down method (Jain et al., 2011). Both qualitatively and
quantitatively, the results obtained with soluble EGFP-PL-B5-
L expressed in 293T cells (Figure 3a and b, Figure 4a,
Supplementary Figure S4a–d online) or in bacteria (Figure 2
and Supplementary Figure S3 online) were similar.
Identification of a second IF-binding site, independent of the
linker, in the plectin C terminus
We took advantage of the simple and powerful FluoBACE
method to further characterize the IF-binding properties of the
plectin C terminus. The longer recombinant protein EGFP-PL-
B5-E (see Figure 1) exhibited qualitatively similar IF-binding
properties to EGFP-PL-B5-L, but its relative binding to various
IF proteins was different, suggesting that the PRD C and/or
the C extremity contribute to the total binding of PL-B5-E
(Figure 3a and b, Supplementary Figure S4a–h online). EGFP-
PL-C-E could indeed interact on its own with IFs but much
more weakly than plectin constructs containing the linker, and
it did not show a clear preference for type I keratins or dimeric
K5/K14 (Figure 3a and b, Supplementary Figure S4i–l online).
To confirm that PL-C-E binds to K5/K14, we performed an
immunofluorescence study in transfected cells and yeast
three-hybrid (Y3H) assays. EGFP-PL-C-E partially colocalized
with the K5/K14 IF network in 87% of transfected HaCat
keratinocytes (100 analyzed cells), whereas EGFP-PL-C exhib-
ited a diffuse pattern in all transfected cells (Figure 3c). In
Y3H, GAL4-DB-PL-C-E was also able to promote the growth
of yeast cells co-transformed with GAL4-AD-K5 and with
GAL4-AD-K14, reflecting the interaction between PL-C-E and
K5/K14 (Figure 5a). These results univocally indicate that other
sequences within plectin can bind to cytokeratins besides
those of the linker region. Hence, plectin and desmoplakin, a
plakin showing high homology to plectin (see Figure 1 in
(Fontao et al., 2003)), contain distinct sequences within their
C-terminal portion that can independently interact with
specific IFs with different selectivity (this study and (Fontao
et al., 2003)).
To confirm that the results obtained with recombinant
plectin C-terminal constructs are relevant to full-length plec-
tin, we tested the IF-binding properties of a hemagglutinin
(HA)-tagged full-length plectin 1c (HA-PL) and those of a
plectin 1c recombinant protein lacking the C-terminal
domains from the PRD B4 to the C extremity, HA-PL-DB4-E
(see Figure 1). Both proteins were expressed in 293 T cells
(Supplementary Figure S5a online). As expected from previous
studies that mapped the IF-binding domain to the plectin C
terminus (Wiche et al., 1993; Nikolic et al., 1996), HA-PL, but
not HA-PL-DB4-E, interacted with monomeric IF proteins and
dimeric K5/K14 (Supplementary Figure S5b and c online). In
three independent experiments, we found a better binding of
HA-PL to monomeric K14, K10, and K18 than to their type II
partners K5, K1, and K8, respectively, as well as a better
binding to dimeric K5/K14 than to monomeric K14. Hence,
the IF-binding properties of full-length plectin 1c and its C
terminus seem similar.
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Figure 2. Recombinant H6-EGFP-PL-B5-L protein preferentially binds to type I keratins and dimeric K5/K14. (a) Fluorescent overlay assays; proteins (0.5mg each)
were separated on 10% SDS-PAGE, transferred onto nitrocellulose membranes, and stained with Ponceau red (type I keratins K10, K14, and K18 are smaller than
their type II partners K1, K5, and K8, respectively). Membranes were then overlaid with pure recombinant H6-EGFP-PL-B5-L or EGFP-H6 (0.5mM each) and
scanned for fluorescence. (b) As for (a), but proteins (K5, K14, dimeric K5/K14, and BSA) were spotted onto nitrocellulose membranes (3.5 pmol protein per spot).
Quantification of overlay assays is presented in Supplementary Figure S3 online. (c) Fluorescent-sorbent binding assays; K5 and K14 (4 pmol) were immobilized as
monomers or mixtures (K5/K14) in wells of ELISA-microtiter plates and incubated with serial dilutions of pure recombinant H6-EGFP-PL-B5-L. Its binding to
intermediate filament proteins was measured with a fluorometer (RU: relative unit); each point represents the mean±SD of four independent experiments. Values
of EGFP-H6 were similar to the blank values (data not shown).
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Multimodular binding of plectin B5-E to IFs
To gain insight into the primary mechanisms underlying
epidermolysis bullosa simplex-muscular dystrophy in patients
carrying truncating mutations in the plectin gene close to the
end of the coding sequence (Schro¨der et al., 2002; Winter and
Wiche, 2013) (see Figure 1), we investigated the K5/K14-
binding properties of C-terminal deletion mutants of PL-B5-E
with FluoBACE. Optimal interaction was observed with PL-
B5-E. Removal of the C extremity from PL-B5-E (PL-B5-C)
significantly reduced its binding to K5/K14. Analysis of the
binding parameters revealed that the apparent Bmax value
(dependent on the number of binding sites) was decreased,
whereas the apparent Kd was unchanged (Figure 4). Trunca-
tion of the C extremity form PL-C-E (PL-C) abolished its weak
binding to K5/K14 (data not shown). Removal of the PRD C
from PL-B5-C (PL-B5-L) affected the apparent Kd, but not the
Bmax value (Figure 4), an observation suggesting a complex
interplay between the different plectin domains. Therefore, all
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Figure 3. The C terminus of plectin bears two separate intermediate filament-binding domains, B5-L and C-E, exhibiting different specificities. (a, b) FluoBACE-
overlay assays; membranes, prepared as for Figure 2a and b, were overlaid with soluble extracts of transiently transfected 293T cells expressing enhanced green
fluorescent protein (EGFP)-tagged PL-B5-L (230 nM), PL-B5-E (140 nM), PL-C-E (340 nM), or EGFP (160 nM) and scanned for fluorescence. Quantification of overlay
assays is presented in Supplementary Figure S4 online. (c) Confocal laser scanning microscope pictures of transiently transfected HaCat keratinocytes expressing
EGFP-PL-C-E or EGFP-C (green), fixed with methanol. Keratins were revealed with the mouse mAb MNF116 (red). Bar ¼ 10mm.
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subdomains within PL-B5-E contribute to its binding to K5/
K14. Similar results were obtained with other IFs, such as
desmin, vimentin, and K8/K18 (data not shown).
Plectin preferentially binds to the coiled-coil 1 of K5/K14
To define regions within K5/K14, which are functionally
important for their binding to plectin, we carried out Y3H
assays using various deletion mutants of K5/K14. The results
show that all tested plectin constructs could promote the
growth of yeast cells co-transformed with the coiled-coil 1
domain constructs but not with constructs encoding the coiled-
coil 2 and tail domains of K5/K14 (Figure 5a). FluoBACE on
filter plates (see Supplementary Materials and Methods online)
confirmed PL-B5-E binding to the rod domain and to the coil 1
of K5/K14 (data not shown). Preferential binding of both EGFP-
PL-B5-L and EGFP-PL-B5-E to the coil 1 versus to the coil 2-tail
of K5/K14 was also found in FluoBACE-overlay assays
(Figure 5b). Nevertheless, EGFP-PL-B5-E could also weakly
interact with the coil 2-tail of K5 and K5/K14, apparently via
the contribution of the C-E domains (Figure 5b). This interac-
tion was not revealed in Y3H assays, probably because it was
too weak. The different binding sites on K5/K14 for PL-C-E or
PL-B5-L could explain the higher binding capacity of PL-B5-E
for K5/K14 compared with smaller recombinant proteins (see
Figure 4). These findings and those of a previous study showing
that plectin specifically associates with the coil 1B domain of
desmin and vimentin (Favre et al., 2011) (our own unpublished
data) suggest that the association of plectin with IF proteins
involves a similar set of sequences among cytokeratins and
type III IF proteins. It is tempting to sponsor this idea for other
IFs, as plectin is able to interact with a large number of them
(Winter and Wiche, 2013).
The quaternary structure of K5/K14 filaments positively affects
their association with plectin
As our results (Figures 2 and 3, Supplementary Figures S3 and
S4 online) indicated that dimerization of K5 and K14 affects
their binding to plectin, a phenomenon previously observed
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Figure 4. All domains of PL-B5-E contribute to its efficient binding to K5/K14.
(a) Fluorescent-sorbent binding assays; K5/K14 (4 pmol), immobilized in wells
of ELISA-microtiter plates, were incubated with serial dilutions of soluble
extracts from 293T cells expressing various enhanced green fluorescent protein
(EGFP)-tagged plectin recombinant proteins (three independent experiments,
four for EGFP-PL-B5-E); data represent means±SD. Values of EGFP-PL-C (up to
400 nM) or EGFP (up to 200 nM) were similar to the blank values (data not
shown). (b, c) Effects of C-terminal truncations of EGFP-PL-B5-E on the
apparent Kd and Bmax calculated from each individual binding curves; t-test
*Po0.05.
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Figure 5. The C terminus of plectin mainly interacts with the coil 1
subdomains of K5/K14. (a) Yeast three-hybrid analysis of the interaction site(s)
of various plectin constructs on K5/K14 by testing several deletion mutants of
K5/K14 (keratin residue numbers are indicated in brackets):  , þ / , and þ
mean no growth, exclusive growth on His selection medium, and growth on
both His and adenine selection media, respectively. (b) FluoBACE-overlay
assays of various plectin constructs on coil 1 (C1) or coil 2 to tail (C2-T) of K5,
K14, and K5/K14 or BSA (0.2mg per spot). For quantification of binding results,
see Supplementary Figure S6 online.
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with desmoplakin (Fontao et al., 2003), we overlaid K5 and
K14 proteins, spotted in different assembly stages, with EGFP-
PL-B5- E (see Figure 1 and experimental conditions in Supple-
mentary Materials and Methods online: FluoBACE-overlay
assay) (Bousquet et al., 2001; Yamada et al., 2002; Herrmann
and Aebi, 2004). As inferred from the signal intensities, the
assembly stage of cytokeratins affected their binding to EGFP-
PL-B5-E (Figure 6b). Indeed, recombinant plectin preferentially
associated with assembled K5/K14 filaments, when compared
with dimeric or tetrameric K5/K14 and monomeric K14
(Figure 6c). On the basis of the results of serial dilution studies,
the different binding ability was mainly due to a variable
number of binding sites for recombinant plectin on K5/K14
filaments (Bmax values) (Figure 6d). The increased number of
binding sites for PL-B5-E on K5/K14 filaments may be because
of either the formation of new binding sites on assembled IFs or
to the oligomerization state of the recombinant plectin protein
via their PRDs (Janda et al., 2001). In line with these ideas,
PL-B5-L is able to induce either aggregation or depolymeriza-
tion of IFs depending on its concentration (Steinbock et al.,
2000). Furthermore, the plectin PRDs undergo homodimeri-
zation and heterodimerization in oxidative conditions (Spurny
et al., 2007), and the dimeric crystal structure of desmoplakin
PRD B appears to also favor the existence of interactions among
PRDs (Choi et al., 2002).
CONCLUSION
We have dissected the binding properties of plectin to
epidermal cytokeratins using several approaches, including
FluoBACE, which is a rapid and sensitive fluorescent protein–
binding assay. Our results reveal a much more complex
interaction mode between plectin and cytokeratins than
previously reported. Beyond the linker region, plectin contains
additional domains within its C terminus contributing to and
directly mediating interaction with IF proteins. Our results
provide a better understanding of the molecular effects of
pathogenic mutations within the plectin C terminus on IF
anchorage and tethering. Although the cytokeratins coil 1 is
the major binding site for plectin, polymerization of keratins
increases their binding capacity to plectin. The latter observa-
tion implies that the quaternary structure of IFs is important for
proper binding to plectin and for their anchorage to mem-
brane sites, such as hemidesmosomes. Hence, it is most likely
that mutations in cytokeratin genes affecting the formation of
an extended IF network have an as yet unrecognized impact
on the binding of plectin and by this means contribute to the
cytoarchitecture disorganization typically observed in epider-
molysis bullosa simplex.
MATERIALS AND METHODS
Cell culture and transfection
Human epithelial kidney 293T and HaCat cells were cultured in
DMEM (Invitrogen, Zug, Switzerland) supplemented with 10% new-
born calf serum (Sigma, St Louis, MO), 100 U ml 1 penicillin, and
100mg ml 1 streptomycin. HEK 293T cells were transfected by a
standard calcium phosphate method, whereas HaCat keratinocytes
were transfected with lipofectamine 2000 (Invitrogen) (Deyrieux and
Wilson, 2007).
Complementary DNA constructs
EGFP was cloned from pEGFP-C3 (Clontech, Saint-Germain-en-Laye,
France) into pET28 (Novagen, Madison, WI), generating the plasmid
p1354 to express EGFP-H6 in Escherichia coli. An adaptor coding for
MGSSHHHHHHSSGLVPRGSHMLDSGGGS was cloned in frame
with the 50end of the EGFP-H6 sequence in p1354 generating
p1454. Mouse plectin 1c fragments (PL-B5-E, residues 3954–4572;
PL-B, res. 3954–4133; PL-B5-L, res. 3954–4266; PL-B5-C, res. 3954–
4502; PL-C-E, res. 4292–4572; PL-C, res. 4289–4506) were cloned
into bacteria p1454, yeast pAS2-1, and mammalian pEGFP-C vectors.
Human HA-plectin 1c in pcDNA3 (HA-PL) was obtained from
Sonnenberg A (NKI, Amsterdam, The Netherlands) (Koster et al.,
2003). HA-PL-DB4-E plasmid encodes plectin 1c without the last 964
residues. Human IF complementary DNAs, their mutants, or fragments
were cloned into yeast pAS2.1 and pACT2 (Clontech) or pACT2-URA
(Fontao et al., 2003), and bacterial pET15b or pET23 (Novagen). K5
and K14 complementary DNAs were given by Birgit Lane (IMB,
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Figure 6. The binding of PL-B5-E to K5/K14 is modulated by the quaternary state of K5/K14 filaments. FluoBACE-overlay assays: (a) K5 and K14 were spotted
onto nitrocellulose membranes as monomers or in different oligomeric forms (see Supplementary Data online, FluoBACE-overlay assay, for exact conditions) (0.2mg
protein per spot). Spotting quality was controlled by Ponceau red staining. (b) Fluorescence scan of a membrane prepared as in a overlaid with EGFP-PL-B5-E
(88 nM). (c) Quantification of b (eight independent experiments), fluorescence values were normalized to K5 (per picomol protein); data represent means±SD,
t-test, *P¼ 0.01, **Po0.005. (d) As for c, with serial dilutions of soluble extracts from 293T cells expressing EGFP-PL-B5-E (two independent experiments); data
represent means±SD.
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Singapore). Constructs were generated by direct subcloning or after
PCR. Correctness of amplified constructs was verified by sequencing.
Antibodies
The following antibodies were used: anti-GFP (B-2, Santa Cruz
Biotechnology, Heidelberg, Germany), anti-H6 (HIS-1, Sigma), anti-
HA (Y-11, Santa Cruz), anti-cytokeratins (MNF116, Dako, Baar,
Switzerland), and anti-vimentin (V9, Sigma). The following secondary
antibodies were used: goat anti-mouse or anti-rabbit-Alexa 488, anti-
Alexa 568 (Invitrogen), or anti-IRDye 800cw (LI-COR, Bad-Homburg,
Germany).
SDS-PAGE and western blotting
SDS-PAGE and western blotting were performed as previously
described (Fontao et al., 2003), except for the systematic use of
secondary antibodies conjugated to IRDye 800cw. Western blot
membranes were scanned with Odyssey (LI-COR). For in-gel
detection of fluorescent proteins, samples were not boiled before
loading and gels were scanned with a Typhoon 9400 (GE-Healthcare,
Glattbrugg, Switzerland).
Yeast two- and three-hybrid assays
Yeast two- and three-hybrid experiments were performed exactly as
previously described (Fontao et al., 2003). For each keratin pair used
in Y3H, their ability to heterodimerize was first verified in yeast two-
hybrid (data not shown) by cloning one of the partners in pAS2.1. For
PL-C-E (see Figure 5a), the mutant S4530G was used to prevent
phosphorylation affecting IF binding (Bouameur et al., 2013).
Recombinant proteins
The E. coli strain BL21 (DE3) was used to produce IF proteins and
plectin mutants from pET vectors (Novagen). Protein expression was
induced with 0.2 mM isopropyl b-D-1-thiogalactopyranoside (Pro-
mega, Du¨bendorf, Switzerland) for 3 h at 37 1C or overnight at
22 1C. Tag-less keratins were purified as previously described
(Fontao et al., 2003). For H6-tagged K10 or keratin fragments,
bacteria were lysed by sonication in 20 mM sodium phosphate,
0.5 M NaCl, 20 mM imidazole, 8 M urea, pH 7.4, and centrifuged at
21,000g for 30 min. Proteins were purified with a His-Trap-FF column
according to the manufacturer’s protocol (GE-Healthcare) and
dialyzed against phosphate-buffered saline, 6 M urea, and 2 mM
dithiothreitol. Recombinant EGFP-H6 and H6-EGFP-PL-B5-L were
affinity-purified as for H6 keratins but without urea. For EGFP-H6,
eluted fractions were dialyzed against 20 mM TrisHCl, pH 8.0, and
refined on a Hi-Trap-Q-FF column (GE-Healthcare) equilibrated in
dialysis buffer. EGFP-H6 was eluted with 1 M NaCl linear gradient and
finally dialyzed against phosphate-buffered saline-dithiothreitol.
FluoBACE interaction assays
FluoBACE assays and related protocols are detailed in Supplementary
Materials and Methods online (Aebi et al., 1983; Stappenbeck et al.,
1993; Steinert et al., 1999). Graphics were generated with GraphPad
software (GraphPad Software, La Jolla, CA), and apparent binding
parameters calculated from the simplified assumption of one binding
site.
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